CordovaCann Corp (LVRLF)
0.0735
+0.02
(+29.04%)
USD |
OTCM |
May 17, 16:00
CordovaCann Price to Book Value
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 17, 2024 | 1.702 |
| May 16, 2024 | 1.319 |
| May 15, 2024 | 1.319 |
| May 14, 2024 | 1.250 |
| May 13, 2024 | 1.389 |
| May 10, 2024 | 1.389 |
| May 09, 2024 | 1.274 |
| May 08, 2024 | 1.852 |
| May 07, 2024 | 1.852 |
| May 06, 2024 | 1.852 |
| May 03, 2024 | 1.852 |
| May 02, 2024 | 1.852 |
| May 01, 2024 | 1.852 |
| April 30, 2024 | 1.686 |
| April 29, 2024 | 2.061 |
| April 26, 2024 | 2.061 |
| April 25, 2024 | 2.061 |
| April 24, 2024 | 2.061 |
| April 23, 2024 | 1.827 |
| April 22, 2024 | 2.084 |
| April 19, 2024 | 2.084 |
| April 18, 2024 | 2.084 |
| April 17, 2024 | 2.084 |
| April 16, 2024 | 1.678 |
| April 15, 2024 | 1.678 |
| Date | Value |
|---|---|
| April 12, 2024 | 1.85 |
| April 11, 2024 | 1.85 |
| April 10, 2024 | 1.85 |
| April 09, 2024 | 1.85 |
| April 08, 2024 | 1.85 |
| April 05, 2024 | 1.852 |
| April 04, 2024 | 1.505 |
| April 03, 2024 | 1.419 |
| April 02, 2024 | 1.181 |
| April 01, 2024 | 1.683 |
| March 28, 2024 | 2.091 |
| March 27, 2024 | 1.060 |
| March 26, 2024 | 1.565 |
| March 25, 2024 | 1.565 |
| March 22, 2024 | 1.568 |
| March 21, 2024 | 1.505 |
| March 20, 2024 | 1.505 |
| March 19, 2024 | 1.158 |
| March 18, 2024 | 1.605 |
| March 15, 2024 | 1.605 |
| March 14, 2024 | 1.204 |
| March 13, 2024 | 1.924 |
| March 12, 2024 | 2.091 |
| March 11, 2024 | 2.091 |
| March 08, 2024 | 1.500 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.060
Minimum
Mar 27 2024
72.29
Maximum
Jul 01 2019
6.608
Average
4.168
Median
Jul 11 2022
Price to Book Value Benchmarks
| Acasti Pharma Inc | 0.3909 |
| Aurinia Pharmaceuticals Inc | 2.180 |
| Edesa Biotech Inc | 3.384 |
| Lexaria Bioscience Corp | 6.225 |
| Xenon Pharmaceuticals Inc | 3.384 |
Price to Book Value Related Metrics
| Price | 0.0735 |
| Market Cap | 8.048M |